NCT00660530View on ClinicalTrials.gov

Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
HyperphosphatemiaKidney Disease
Interventions
DRUG

Lanthanum Carbonate Chewable Product

Lanthanum carbonate 1 g to be chewed, three times daily with meals

DRUG

Lanthanum carbonate crushed powder

Lanthanum carbonate (Fosrenol) 1 g crushed into a fine powder, three times daily with meal

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

University of Illinois at Chicago

OTHER

NCT00660530 - Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients | Biotech Hunter | Biotech Hunter